Topic

Illinois

A collection of 499 issues

Getting Zokinvy (Lonafarnib) Approved by Blue Cross Blue Shield in Illinois: Complete Guide to Prior Authorization and Appeals

Answer Box: Get Zokinvy Covered by BCBS Illinois Blue Cross Blue Shield of Illinois requires prior authorization for Zokinvy (lonafarnib) with specific documentation: genetic confirmation of HGPS, patient ≥12 months old with BSA ≥0.39 m², and prescription by a geneticist or pediatric cardiologist. Submit through the BCBS provider portal

Blue Cross Blue Shield Illinois Coverage Criteria for Nucala (Mepolizumab): What Counts as "Medically Necessary"?

Quick Answer: Getting Nucala Covered by Blue Cross Blue Shield in Illinois Blue Cross Blue Shield of Illinois requires prior authorization for Nucala with specific medical necessity criteria: blood eosinophil count ≥150 cells/μL (recent) or ≥300 cells/μL (past year), documented severe eosinophilic asthma despite 3+ months of high-dose

Vitrakvi (Larotrectinib) Approval with UnitedHealthcare in Illinois: Answers to the Most Common Questions

Quick Answer: Getting Vitrakvi Covered by UnitedHealthcare in Illinois Yes, UnitedHealthcare covers Vitrakvi (larotrectinib) in Illinois, but requires prior authorization with documented NTRK gene fusion testing. The fastest path: have your oncologist submit a PA request through OptumRx with your molecular pathology report, staging documentation, and prior therapy history. If

How to Get Lumizyme (Alglucosidase Alfa) Covered by Cigna in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Lumizyme Covered by Cigna in Illinois Cigna requires prior authorization for Lumizyme (alglucosidase alfa) in Illinois. To get approval, you need: (1) confirmed Pompe disease diagnosis with enzyme/genetic testing, (2) specialist prescriber documentation, and (3) medical necessity letter showing clinical rationale. If denied, Illinois provides automatic

How to Get Retevmo (Selpercatinib) Covered by Humana in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Retevmo (Selpercatinib) Covered by Humana in Illinois Retevmo requires prior authorization from Humana and is typically non-formulary, requiring a formulary exception request. The fastest path to approval: 1) Confirm RET alteration with FDA-approved genetic testing, 2) Have your oncologist submit a comprehensive prior authorization through Humana'

How to Get Ibrance (Palbociclib) Covered by Aetna CVS Health in Illinois: Complete Requirements Checklist and Appeals Guide

Quick Answer: Getting Ibrance Covered by Aetna CVS Health in Illinois Aetna CVS Health requires prior authorization for Ibrance (palbociclib) in Illinois with mandatory step therapy requirements. You'll need documented HR+/HER2- metastatic breast cancer, evidence of prior endocrine therapy failure, and submission through CVS Specialty Pharmacy. First

How to Get Zanzalintinib (XL092) Covered by Blue Cross Blue Shield in Illinois: Complete Appeals Guide for Investigational Cancer Drugs

Answer Box: Getting Zanzalintinib (XL092) Covered in Illinois Zanzalintinib (XL092) is investigational and typically excluded from Blue Cross Blue Shield of Illinois coverage. Your fastest path: 1) Apply for Exelixis expanded access program (free drug, 30-60 days), 2) Submit prior authorization with robust medical necessity documentation, and 3) If denied,

Work With Your Doctor to Get Waylivra (Volanesorsen) Covered by Blue Cross Blue Shield in Illinois: Complete Provider Collaboration Guide

Answer Box: Your Path to Waylivra Coverage in Illinois Waylivra (volanesorsen) isn't typically covered by Blue Cross Blue Shield of Illinois because it's not FDA-approved for FCS in the US. However, you can work with your doctor to request a formulary exception through detailed medical documentation

Get Jakafi (Ruxolitinib) Covered by Cigna in Illinois: Complete Guide to Forms, Appeals, and Approval

Quick Answer: Getting Jakafi (Ruxolitinib) Covered by Cigna in Illinois Cigna requires prior authorization for Jakafi (ruxolitinib) in Illinois. Your physician must submit a PA request through CoverMyMeds or fax the Illinois-specific form to Cigna. Key requirements include documented diagnosis (myelofibrosis, polycythemia vera, or GVHD), prior therapy failures for PV

How to Get Ultomiris (Ravulizumab) Covered by Cigna in Illinois: Complete PA Guide and Appeal Process

Quick Answer: Getting Ultomiris Covered by Cigna in Illinois Ultomiris requires prior authorization from Cigna for all conditions (PNH, aHUS, gMG, NMOSD). Submit the official Cigna PA form with complete diagnosis documentation, specialist involvement, and vaccination records. Most requests are processed within 5-7 business days. If denied, you have 180